FDA chief highlights huge price gaps in medical devices

The Food and Drug Administration (FDA) chief Tukaram has flagged significant price disparities in medical devices across the country. He has urged the central government to intervene to regulate the soaring costs, which vary drastically between regions and suppliers.

Tukaram pointed out that the price differences for essential medical devices are alarmingly high, with some items showing gaps of over 2,800 percent. He stressed that such disparities are affecting accessibility and affordability for patients who rely on these devices for treatment.

The FDA chief called for immediate action from the Centre to standardize pricing and ensure that medical devices are available at fair prices nationwide. He emphasized the need for regulatory measures to prevent exploitation and to protect public health interests.